William Schilling

9PUBLICATIONS
99CO-AUTHORS
Epidemiological modellingPharmacogenomicsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 12, 2024
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

William H K Schilling, Mavuto Mukaka, James J Callery

|Jul 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).

Podjanee Jittamala, William H K Schilling, James A Watson

|Mar 06, 2023
Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study.

Carlo Perrone, William Schilling, James J Callery

|Feb 21, 2023
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).

William H K Schilling, Podjanee Jittamala, James A Watson

|Mar 21, 2022
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project.

Arjun Chandna, Rusheng Chew, Nan Shwe Nwe Htun

|Oct 11, 2021
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions.

William Hk Schilling, James J Callery, Arjun Chandna

Pageof 2

Frequent Collaborators

7 joint publications

Nicholas J White

5 joint publications

James A Watson

5 joint publications

James J Callery

4 joint publications

Arjen M Dondorp